Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-26 @ 5:07 PM
Study NCT ID:
NCT01363232
Status:
COMPLETED
Last Update Posted:
2020-10-05
First Post:
2011-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
Sponsor:
Array Biopharma, now a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-08
Start Date Type:
None
Primary Completion Date:
2014-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12-18
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-24
First Submit QC Date:
None
Study First Post Date:
2011-06-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-30
Last Update Post Date:
2020-10-05
Last Update Post Date Type:
ACTUAL